Transaction #7669 · Form 4 · 0000939767-25-000134
EXELIXIS, INC. · Exercise / conversion · Common Stock
EXELIXIS, INC. · Transacted November 11, 2025 · Filed November 13, 2025
What does this filing report?
An SEC Form 4 filing for EXELIXIS, INC. records an exercise / conversion involving Common Stock on November 11, 2025. The reported quantity was 5,784. The filing date is November 13, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- EXELIXIS, INC.
- Company CIK
- 0000939767
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 5,784
- Reported price
- 23.24
- Reference value
- 134,420.16
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 46,002
- Ownership description
- Not reported
- SEC acceptance time
- Nov 13, 2025, 7:12 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Beckerle Mary C ↗
Director
CIK 0001520181
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- F2
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3
- The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.